This is a non-core endpoint: only basic statistics are computed.
Contusion of toe(s) with damage to nail
ST19_CONTU_TOES_W_DAMAGE_NAIL
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
403 |
4. Check minimum number of eventsNone |
403 |
5. Include endpointsNone |
403 |
6. Filter based on genotype QC (FinnGen only) |
403 |
Control definitions (FinnGen only)
- Control exclude
- ST19_INJURI_ANKLE_FOOT
Extra metadata
- Level in the ICD hierarchy
- 4
- First used in FinnGen datafreeze
- DF4
- Parent code in ICD-10
- S90
- Name in latin
- Contusio digiti/digitorum pedis cum laesione unguis/unguium
Similar endpoints
↥List of similar endpoints to
Contusion of toe(s) with damage to nail
based on the number of shared cases.
Similar with more cases:
- Superficial injury of ankle and foot
- Injuries to the ankle and foot
- Injury, poisoning and certain other consequences of external causes
- Any event in hilmo or specialist outpatient
- Any prescribed medicine buy
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 403 | 210 | 193 |
| Unadjusted period prevalence (%) | 0.08 | 0.07 | 0.09 |
| Median age at first event (years) | 45.36 | 40.56 | 50.59 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 359
- Matched controls
- 3588
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
S90.2
ICD-10 Finland
Contusion of toe(s) with damage to nail
+∞
323.0
359
10
W22
ICD-10 Finland
Striking against or struck by other object(s)
10.4
43.1
90
112
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
9.9
35.0
74
92
X58
ICD-10 Finland
Exposure to other specified factors
4.4
22.2
89
248
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
3.4
20.0
117
446
NH3BA
NOMESCO Finland
Foot and toes extensive X-ray examination
16.5
18.3
29
19
X59
ICD-10 Finland
Exposure to unspecified factor
3.2
15.9
95
360
L17
ICPC
Foot/toe symptom/complaint
2.9
15.0
113
496
S92.3
ICD-10 Finland
Fracture of metatarsal bone
33.3
14.9
19
6
M79.6
ICD-10 Finland
Pain in limb
2.5
14.1
145
759
S92.4
ICD-10 Finland
Fracture of great toe
36.3
11.3
14
*
S93.4
ICD-10 Finland
Sprain and strain of ankle
3.8
10.4
45
131
N02AX02
ATC
tramadol; systemic, rectal
2.0
8.6
133
802
NHQ40
NOMESCO Finland
Amputation of toe
13.2
8.4
14
11
NH1AA
NOMESCO Finland
Ankle X-ray examination without contrast
4.6
7.6
25
57
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.9
7.6
187
1321
W19
ICD-10 Finland
Unspecified fall
3.1
7.4
41
144
J01DB01
ATC
cefalexin; oral
2.0
7.0
294
2470
N02BE01
ATC
paracetamol; systemic, rectal
2.1
7.0
295
2483
W20
ICD-10 Finland
Struck by thrown, projected or falling object(s)
11.2
6.8
12
11
S91.3
ICD-10 Finland
Open wound of other parts of foot
9.6
6.8
13
14
L03.0
ICD-10 Finland
Cellulitis of finger and toe
3.2
6.6
34
115
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.8
6.6
191
1398
M01AB05
ATC
diclofenac; systemic, rectal
1.8
6.5
219
1679
NH1AD
NOMESCO Finland
Ankle and foot CT
14.6
6.4
10
7
S92.5
ICD-10 Finland
Fracture of other toe
7.2
6.3
14
20
S92.9
ICD-10 Finland
Fracture of foot, unspecified
+∞
6.3
6
*
XPX99
NOMESCO Finland
Other diagnostic examination of periferal vessel
3.7
6.3
26
75
S80.0
ICD-10 Finland
Contusion of knee
3.2
6.2
31
104
J01DA01
ATC
[U] cefalexin; systemic
1.7
6.2
211
1615
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
182
1211
1.92
9.18
7.3
6.4
mmol/l
1.2
1.2
0.13
165
1108
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
192
1357
1.79
7.55
8.9
7.0
mmol/l
1.2
1.2
0.16
163
1153
(3032080) INR in Blood by Coagulation assay
156
1047
1.80
7.23
8.4
7.4
inr
1.2
1.2
0.14
55
326
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
153
1025
1.79
7.11
4.3
3.1
ng/l
34.7
39.8
0.18
95
614
(3026782) Osmolality of Urine
96
568
1.91
6.57
3.8
2.5
mosm/kgh2o
584.5
580.8
0.05
79
483
(3013826) Glucose [Moles/volume] in Serum or Plasma
227
1749
1.68
6.08
5.7
4.8
mmol/l
6.7
6.6
0.26
218
1595
(3013707) Erythrocyte sedimentation rate by Westergren method
282
2305
1.74
6.04
4.5
3.7
mm/h
10.9
10.1
0.47
269
2130
(3042936) Bacteria identified in Isolate by Culture
70
388
1.97
5.76
2.4
2.0
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
11
21
5.36
5.55
3.6
3.5
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
147
1050
1.63
5.03
4.2
2.9
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
149
1073
1.62
4.91
2.2
1.8
pmol/l
95.2
96.8
0.15
87
572
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
34
151
2.37
4.88
1.3
1.3
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
102
671
1.70
4.77
1.9
1.9
mg/l
0.9
1.1
0.45
70
495
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
280
2351
1.63
4.74
8.8
7.0
u/l
77.4
77.5
0.02
266
2205
(3026493) Urate [Moles/volume] in Serum or Plasma
108
723
1.67
4.72
2.8
2.7
umol/l
338.6
5403.7
2.28
92
633
(3000494) Fungus identified in Specimen by Culture
61
346
1.90
4.67
1.2
1.4
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
42
208
2.14
4.67
2.3
2.6
ml/min/173m2
62.6
72.6
0.52
17
87
(3026008) Bacteria identified in Urine by Culture
119
819
1.64
4.67
2.8
2.6
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
72
431
1.82
4.66
4.3
3.8
mmol/l
0.8
0.8
0.08
66
407
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
118
815
1.63
4.55
2.6
2.1
u/l
159.6
363.5
1.02
112
769
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
195
1516
1.55
4.54
7.1
6.2
umol/l
10.8
11.1
0.11
186
1433
(3002032) Base excess in Venous blood by calculation
48
254
2.01
4.49
6.9
5.3
mmol/l
1.5
1.4
0.08
40
200
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
19
66
2.97
4.39
1.6
1.7
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
73
447
1.77
4.38
1.9
1.6
nmol/l
1206.2
1221.9
0.05
54
346
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
337
2997
1.76
4.28
4.5
3.9
mmol/l
6.1
5.8
2.20
311
2764
(3012544) pH of Venous blood
49
266
1.96
4.27
6.9
5.4
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
362
3294
1.97
4.21
17.2
11.6
mg/l
17.0
21.8
3.24
303
2521
(3037467) Urinalysis macro (dipstick) panel - Urine
259
2165
1.55
4.20
4.6
3.9
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
53
298
1.90
4.17
23.9
17.7
inr
1.3
1.2
—
10
59
(3000850) Epithelial cells [#/volume] in Urine
91
605
1.65
4.03
3.3
2.3
e6/l
5.0
6.8
0.52
76
532
(3002582) Erythrocytes [#/volume] in Urine
125
898
1.57
4.03
4.1
2.8
e6/l
34.8
125.4
0.65
99
683
(3013512) EKG study
108
753
1.59
3.95
5.7
3.4
—
—
—
0
0
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
31
146
2.22
3.92
5.4
5.7
mmol/l
24.1
23.7
0.35
26
138
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
185
1456
1.50
3.88
4.6
4.1
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
84
553
1.66
3.86
1.8
1.7
pmol/l
435.6
28571852.1
0.80
71
476
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
14
44
3.26
3.81
1.5
1.4
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
14
44
3.26
3.81
1.5
1.4
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
354
3221
1.81
3.79
19.3
12.7
mmol/l
139.5
139.6
0.41
345
3131
(3013650) Neutrophils [#/volume] in Blood by Automated count
226
1862
1.49
3.73
10.0
9.0
e9/l
3.8
4.0
1.25
201
1620
(3013115) Eosinophils [#/volume] in Blood
207
1676
1.48
3.72
7.4
6.5
e9/l
0.2
0.2
0.07
186
1492
(42870588) Differential panel, method unspecified - Blood
140
1048
1.51
3.69
7.8
6.0
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
12
35
3.50
3.64
2.2
1.4
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
354
3233
1.78
3.57
19.2
12.7
mmol/l
4.0
4.0
1.21
344
3136
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
291
2539
1.53
3.52
3.6
3.5
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
102
719
1.56
3.52
5.0
4.2
—
—
—
0
0
(3006315) Basophils [#/volume] in Blood
200
1623
1.46
3.47
7.0
6.1
e9/l
0.0
0.0
0.04
179
1419
(3018418) pH of Serum or Plasma
109
785
1.53
3.41
5.2
3.8
ph
7.4
7.4
0.77
23
146
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
65
414
1.68
3.38
1.8
1.8
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
199
1621
1.45
3.35
6.9
6.0
e9/l
0.5
0.6
1.54
179
1417
(3019225) pH of Specimen
45
260
1.82
3.27
4.7
4.3
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
16
60
2.74
3.26
1.8
1.3
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
155
1209
1.46
3.26
2.0
2.0
—
—
—
0
0
(3006504) Eosinophils/100 leukocytes in Blood
188
1523
1.44
3.22
7.4
6.2
%
2.9
2.8
0.16
177
1426
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
10
28
3.64
3.21
2.3
1.3
%
49.8
60.6
—
5
21
(3010813) Leukocytes [#/volume] in Blood
393
3747
2.97
3.16
25.2
17.2
e9/l
6.7
6.7
0.14
386
3652
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
102
736
1.52
3.14
2.3
2.1
mg/l
3.1
3.0
0.16
89
627
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
269
2335
1.46
3.13
3.4
3.1
u/l
45.5
42.3
0.39
250
2227
(3007853) Bacteria identified in Skin by Aerobe culture
56
350
1.70
3.12
2.0
1.5
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
58
366
1.68
3.12
3.9
2.3
%
24.2
24.5
0.04
52
322
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
78
533
1.57
3.06
1.3
1.3
iu/ml
13.1
39.0
4.14
20
169
(3019069) Monocytes/100 leukocytes in Blood
188
1534
1.42
3.04
7.8
6.4
%
8.2
8.4
0.52
179
1447
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
152
1194
1.44
3.03
2.5
2.3
nmol/l
69.0
73.1
1.24
142
1075
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
278
2439
1.45
2.97
4.4
3.7
pmol/l
14.4
14.6
0.54
254
2237
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
23
108
2.20
2.96
2.2
2.0
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
329
2986
1.55
2.96
15.3
10.5
ml/min/173m2
87.2
88.7
0.50
269
2411
(3019198) Lymphocytes [#/volume] in Blood
202
1677
1.41
2.93
7.0
6.1
e9/l
2.1
1.9
0.54
184
1498
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
124
944
1.45
2.90
3.1
2.5
u/l
48.9
55.7
1.92
112
882
(3026361) Erythrocytes [#/volume] in Blood
392
3745
2.71
2.90
25.2
17.1
e12/l
4.5
4.6
0.71
386
3654
(3022096) Basophils/100 leukocytes in Blood
181
1477
1.41
2.88
7.7
6.3
%
0.7
0.7
0.71
172
1384
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
54
342
1.67
2.87
4.4
3.9
%
31.8
31.7
0.04
38
233
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
370
3464
1.83
2.87
11.4
9.2
u/l
28.0
27.7
0.11
357
3353
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
35
195
1.87
2.86
3.5
4.0
mmol/l
1.3
1.5
0.14
23
136
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
326
2961
1.53
2.84
5.2
4.3
mu/l
1.9
2.2
0.42
299
2740
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
22
104
2.18
2.80
2.0
1.8
—
—
—
0
0
(3002030) Lymphocytes/100 leukocytes in Blood
192
1590
1.40
2.78
7.5
6.2
%
30.9
28.8
1.81
180
1499
(3018010) Neutrophils/100 leukocytes in Blood
189
1567
1.39
2.69
7.0
6.1
%
54.9
56.6
1.24
176
1481
(3037522) Nuclear Ab [Titer] in Serum
66
448
1.57
2.66
1.6
1.3
titre
504.0
364.1
—
10
87
(3021589) Normoblasts [#/volume] in Blood
179
1474
1.39
2.64
10.7
8.9
e9/l
0.0
0.0
0.14
150
1208
(3009508) Creatinine [Moles/volume] in Urine
116
888
1.43
2.60
3.5
3.2
mmol/l
7.7
8.4
0.57
90
770
(3001122) Ferritin [Mass/volume] in Serum or Plasma
184
1525
1.38
2.60
3.4
2.7
ug/l
94.2
98.8
0.20
175
1423
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
67
459
1.55
2.59
3.5
2.6
e6/l
5.3
2.0
1.34
39
245
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
73
510
1.53
2.59
1.3
1.3
u/ml
10.9
14.8
0.17
28
207
(3009343) pH of Capillary blood
35
202
1.80
2.58
3.6
3.9
ph
7.4
7.4
—
7
21
(40761511) CBC panel - Blood by Automated count
369
3470
1.75
2.56
16.5
10.8
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
18
82
2.25
2.51
1.9
1.4
ug/g
285.6
301.6
0.13
13
43
(3020682) Albumin/Creatinine [Ratio] in Urine
101
759
1.44
2.50
5.7
4.2
mg/mmol
17.4
12.2
0.21
68
502
(3030467) Casts [#/volume] in Urine by Automated count
106
804
1.43
2.49
4.2
2.7
e6/l
0.4
0.4
0.10
79
597
(3018095) Leukocytes [#/volume] in Urine
135
1069
1.40
2.49
4.8
3.2
e6/l
91.6
82.3
0.06
107
737
(3004588) Protein electrophoresis panel - Serum or Plasma
30
167
1.86
2.48
2.2
2.0
—
—
—
0
0
(4306422)
13
51
2.60
2.47
1.2
1.3
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
390
3740
2.33
2.44
25.3
17.2
e9/l
247.4
253.2
1.11
384
3653
(36304419) Bacteria [Presence] in Urine
105
799
1.42
2.42
4.1
2.6
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
86
631
1.46
2.40
1.6
1.5
nmol/l
21.2
20.6
0.15
76
540
(3002179) Metamyelocytes/100 leukocytes in Blood
38
230
1.72
2.40
4.6
4.2
%
1.3
0.4
—
7
54
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
44
279
1.65
2.35
3.6
3.0
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
148
1200
1.37
2.34
5.7
4.8
g/l
36.5
36.5
0.03
141
1136
(3030905) Polymorphonuclear cells [#/volume] in Blood
14
59
2.42
2.32
2.8
3.3
e9/l
3.7
4.3
1.14
14
59
(3012516) Albumin [Mass/volume] in Urine
95
717
1.43
2.28
3.9
3.4
mg/l
757.8
167.7
0.42
66
484
(3044640) Blood type and Crossmatch panel - Blood
121
953
1.39
2.28
3.4
2.2
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
7
18
3.94
2.26
2.4
3.8
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
13
54
2.45
2.22
3.3
6.6
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
15
67
2.29
2.20
1.2
1.3
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
35
213
1.70
2.18
2.1
2.2
u/l
4148.6
3728.0
0.04
16
84
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
95
723
1.41
2.17
3.1
2.2
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
40
253
1.65
2.17
5.2
4.4
%
1.3
0.9
0.28
12
80
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
14
62
2.30
2.10
2.9
3.4
%
56.1
56.5
0.04
14
62
(3019060) Gas panel - Arterial blood
27
155
1.80
2.06
7.3
7.8
—
—
—
0
0
(40768443) Skin Pathology biopsy report
22
118
1.91
2.06
1.1
1.2
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
116
922
1.36
2.04
2.0
2.0
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
42
274
1.59
2.02
1.9
2.6
g/l
0.2
0.2
0.36
36
252
(3017143) Hepatitis C virus Ab [Presence] in Serum
68
493
1.46
2.02
1.9
1.7
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
31
187
1.71
2.01
1.2
1.2
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
16
77
2.12
1.99
1.7
1.9
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
8
27
3.00
1.94
1.5
1.4
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
338
3157
1.44
1.94
4.8
4.2
mmol/l
2.7
2.8
2.30
313
2943
(3000991) Gas panel - Venous blood
37
237
1.62
1.92
11.9
8.9
—
—
—
0
0
(4146454)
7
22
3.22
1.88
1.7
3.0
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
8
28
2.89
1.87
1.3
1.7
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
37
239
1.60
1.87
5.5
4.6
%
0.0
0.1
—
9
72
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
334
3119
1.41
1.87
4.4
3.9
mmol/l
4.5
4.7
2.42
310
2932
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
6
17
3.57
1.84
2.7
2.4
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
15
73
2.10
1.83
1.1
1.1
u/ml
14.4
7.5
—
8
43
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
50
348
1.50
1.83
3.7
3.6
umol/l
10.9
8.4
0.24
42
301
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
55
392
1.47
1.79
1.9
1.7
—
—
—
0
0
(3033658) Prothrombin time (PT) actual/Normal
95
748
1.35
1.76
5.4
3.9
%
86.3
92.4
1.65
90
740
(3003396) Base excess in Arterial blood by calculation
41
277
1.53
1.72
9.5
9.8
mmol/l
0.4
1.0
0.43
31
223
(3019230) Fractional oxyhemoglobin in Venous blood
10
42
2.42
1.69
3.2
6.2
%
67.5
65.5
—
10
42
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
16
83
1.97
1.67
1.2
1.1
u/ml
0.2
1.4
—
5
35
(3028271) Lactate [Moles/volume] in Capillary blood
8
31
2.61
1.66
2.0
2.1
mmol/l
1.6
1.6
—
8
31
(3008401) Mugwort IgE Ab [Units/volume] in Serum
14
69
2.07
1.66
1.1
1.1
u/ml
0.4
0.6
—
6
35
(3023520) Reticulocytes [#/volume] in Blood
32
206
1.60
1.65
3.3
2.9
e9/l
67.6
72.5
0.22
23
154
(3029937) Albumin [Presence] in Urine by Test strip
104
838
1.32
1.65
4.5
3.3
estimate
0.0
0.0
0.88
42
305
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
23
136
1.73
1.62
1.5
1.5
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
114
933
1.31
1.62
3.2
3.0
mmol/l
2.4
2.3
1.25
95
826
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
41
282
1.51
1.60
1.7
1.7
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
6
20
3.03
1.58
1.5
1.2
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
321
3002
1.34
1.58
4.0
3.6
mmol/l
1.4
1.3
1.50
294
2798
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
65
490
1.39
1.58
1.7
1.7
%
1.4
1.5
0.07
58
441
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
41
283
1.50
1.57
1.7
1.7
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
45
317
1.47
1.57
1.7
1.5
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
12
58
2.10
1.50
1.1
1.2
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
101
823
1.30
1.47
1.6
1.6
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
26
164
1.63
1.47
2.6
1.8
—
—
—
0
0
(3013290) Carbon dioxide [Partial pressure] in Blood
11
52
2.15
1.45
7.2
2.9
kpa
5.1
5.0
0.23
11
52
(3027315) Oxygen [Partial pressure] in Blood
11
52
2.15
1.45
7.2
2.9
kpa
8.9
8.8
0.07
11
52
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
28
181
1.59
1.44
1.9
1.5
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
33
476
0.67
1.44
1.2
1.3
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
20
118
1.73
1.44
2.8
2.0
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
330
3111
1.34
1.44
4.4
3.9
mmol/l
1.4
1.4
2.77
303
2907
(3025130) Human papilloma virus identified in Specimen
10
46
2.20
1.41
2.0
1.8
—
—
—
0
0
(4268621)
9
40
2.28
1.41
2.3
2.1
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
40
282
1.46
1.40
4.9
3.1
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
20
119
1.72
1.40
2.2
1.7
—
—
—
0
0
(40758558) Short blood count panel - Blood
96
782
1.30
1.40
9.4
6.6
—
—
—
0
0
(3022806) Fractional oxyhemoglobin in Capillary blood
7
29
2.44
1.40
1.4
1.7
%
91.9
91.5
—
7
29
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
128
1083
1.27
1.38
3.6
3.3
u/l
30.3
32.4
0.45
121
1032
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
14
75
1.90
1.36
3.1
2.2
ug/min
108.8
127.0
—
9
46
(3001019) Free T4 and TSH panel - Serum or Plasma
12
219
0.53
1.34
1.3
1.6
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
30
201
1.53
1.34
1.4
1.5
iu/l
20.5
20.9
0.03
24
169
(3009542) Hematocrit [Volume Fraction] of Blood
334
3164
1.32
1.33
17.6
12.4
%
40.3
40.6
0.30
251
2510
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
63
487
1.35
1.32
3.0
3.2
ng/l
43.6
260.7
1.55
37
336
(3043238) Trisomy 21 risk [Likelihood] in Fetus
6
133
0.44
1.30
1.3
1.5
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
17
100
1.73
1.25
1.3
1.1
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
38
272
1.44
1.25
3.1
2.4
u/l
378.4
32.8
0.48
33
234
(40768795) Lymph node Pathology biopsy report
6
25
2.42
1.25
1.7
1.2
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
41
298
1.42
1.24
2.7
2.2
nmol/l
11.9
13.9
0.64
36
277
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
16
262
0.59
1.23
1.4
1.3
—
—
—
0
0
(3022145) Colonoscopy Study observation
44
325
1.40
1.22
1.2
1.4
—
—
—
0
0
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
14
78
1.82
1.22
1.1
1.4
mmol/l
4.0
3.7
0.42
14
73
(3051651) Icteric interference index of Serum or Plasma
5
19
2.65
1.22
2.0
2.2
—
—
—
0
0
(3011648) Oxygen content in Venous blood
5
19
2.65
1.22
2.2
11.4
%
11.4
12.6
—
5
19
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
8
38
2.13
1.19
1.1
1.7
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
6
128
0.46
1.18
1.3
1.4
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
14
79
1.80
1.18
1.9
2.8
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
6
129
0.46
1.18
1.3
1.4
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
81
661
1.28
1.17
2.4
2.7
ng/l
2011.7
1102.1
0.60
62
535
(40760892) CBC W Ordered Manual Differential panel - Blood
95
795
1.26
1.12
4.3
4.7
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
20
129
1.58
1.07
1.8
1.3
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
90
752
1.25
1.07
1.8
1.7
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
34
247
1.41
1.06
1.4
1.3
iu/ml
47.8
134.0
2.47
12
103
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
92
773
1.25
1.05
1.7
1.6
mmol/l
1.6
1.4
0.87
75
660
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
16
98
1.66
1.05
1.6
1.6
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
16
98
1.66
1.05
1.6
1.6
g/l
3.8
3.9
—
10
72
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
16
98
1.66
1.05
1.6
1.6
g/l
7.4
7.3
0.04
11
76
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
26
180
1.48
1.03
8.4
8.0
mmol/l
25.8
25.0
0.71
26
180
(3008757) Leukocyte morphology finding [Identifier] in Blood
7
34
2.08
1.03
8.0
3.3
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
9
47
1.94
1.02
2.6
2.5
—
—
—
0
0
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
18
115
1.59
1.01
1.6
1.7
—
226.7
—
0
6
(3037756) Immunofixation for Serum or Plasma
9
48
1.89
1.01
1.4
1.5
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
296
2795
1.22
1.00
7.1
4.9
mmol/mol
41.2
38.8
2.48
276
2634
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
9
49
1.86
0.99
1.4
1.3
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
19
124
1.56
0.98
9.0
13.7
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
60
483
1.28
0.97
3.3
2.4
e6/l
1.4
0.9
0.50
31
268
(3003694) ABO and Rh group [Type] in Blood
120
1049
1.20
0.93
1.6
1.6
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
31
228
1.39
0.92
6.3
4.6
%
0.0
0.1
—
7
59
(3051611) Lipemic interference index of Serum or Plasma
6
28
2.16
0.92
2.0
2.4
—
—
—
0
0
(3009445) Proteinase 3 Ab [Units/volume] in Serum
21
143
1.49
0.91
1.3
1.6
—
10.1
—
0
5
(3013139) Helicobacter pylori Ag [Presence] in Stool
26
187
1.42
0.87
1.2
1.2
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
6
30
2.01
0.87
1.3
1.2
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
107
932
1.20
0.86
4.8
4.3
ug/l
2.0
2.3
0.20
91
840
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
8
45
1.79
0.84
7.4
2.4
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
11
177
0.61
0.83
1.4
1.5
—
—
—
0
0
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
13
81
1.63
0.82
1.5
1.2
—
—
—
0
0
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
6
32
1.89
0.82
1.3
1.4
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
82
700
1.22
0.81
2.6
2.2
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
8
47
1.72
0.81
1.1
1.5
—
—
—
0
0
(3022313) Gas panel - Capillary blood
22
156
1.43
0.80
4.1
3.9
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
22
156
1.43
0.80
1.5
1.7
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
8
48
1.68
0.79
2.6
3.2
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
23
313
0.72
0.78
1.3
1.5
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
0
27
0.00
0.77
0.0
1.0
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
6
34
1.78
0.76
1.0
1.1
—
—
—
0
0
(1616796) Gas panel - Central venous blood
9
54
1.68
0.75
9.0
2.6
—
—
—
0
0
(3035999) Lactate [Moles/volume] in Cerebral spinal fluid
5
24
2.10
0.74
1.0
1.2
mmol/l
1.9
1.8
—
5
24
(3044927) Protein electrophoresis panel - Urine
5
24
2.10
0.74
1.4
1.2
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
40
319
1.28
0.72
5.6
5.9
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
5
26
1.93
0.71
1.0
1.1
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
7
41
1.72
0.70
1.4
1.3
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
47
385
1.25
0.69
1.3
1.2
—
—
—
0
0
(3044889) 12 lead EKG panel
221
2071
1.15
0.69
3.7
3.3
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
11
69
1.61
0.69
1.3
1.6
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
7
42
1.68
0.68
1.0
1.5
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
7
42
1.68
0.68
1.0
1.5
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
5
27
1.86
0.68
1.4
1.1
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
5
28
1.80
0.66
1.4
1.1
—
—
—
0
0
(3020891) Body temperature
15
103
1.47
0.66
2.6
4.8
—
—
—
0
0
(3016724) Homocysteine [Moles/volume] in Serum or Plasma
5
29
1.73
0.64
1.4
1.4
umol/l
10.4
11.4
—
5
29
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
5
30
1.67
0.61
1.0
1.6
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
0
20
0.00
0.60
0.0
1.1
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
11
72
1.54
0.59
1.8
1.2
—
—
—
0
0
(4198724)
0
22
0.00
0.59
0.0
1.7
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
8
53
1.52
0.58
1.1
1.6
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
20
150
1.35
0.57
1.2
1.4
miu/ml
273.7
319.4
—
10
75
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
45
377
1.22
0.56
1.8
2.0
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
15
107
1.42
0.56
1.8
2.2
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
9
61
1.49
0.54
1.0
1.2
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
6
39
1.55
0.53
1.7
1.8
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
72
634
1.17
0.53
2.5
2.0
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
10
67
1.51
0.50
1.5
2.1
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
18
136
1.34
0.50
1.6
1.3
—
—
—
0
0
(4035726)
27
217
1.26
0.49
1.3
1.5
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
13
93
1.41
0.48
1.5
1.1
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
7
48
1.47
0.47
1.1
1.7
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
7
50
1.41
0.45
1.6
1.3
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
7
50
1.41
0.45
1.1
1.7
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
10
69
1.46
0.44
1.1
1.4
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
17
130
1.32
0.44
1.8
1.7
—
—
—
0
0
(4062490)
5
32
1.57
0.42
2.0
1.3
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
5
32
1.57
0.42
1.2
1.4
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
8
57
1.41
0.42
1.1
1.2
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
36
306
1.19
0.41
1.8
1.8
—
—
—
0
0
(3022621) pH of Urine by Test strip
23
186
1.25
0.41
4.3
2.2
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
31
260
1.21
0.41
2.5
2.5
g/l
12.0
10.6
0.38
31
237
(3042299) inFLIXimab [Mass/volume] in Serum or Plasma
0
17
0.00
0.40
0.0
4.8
—
8.1
—
0
17
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
0
17
0.00
0.40
0.0
1.1
—
21.2
—
0
17
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
5
34
1.48
0.40
1.2
1.1
—
—
—
0
0
(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal
5
34
1.48
0.40
1.4
1.1
nmol/l
0.9
1.4
—
5
29
(3029075) Extractable nuclear Ab panel - Serum
0
18
0.00
0.40
0.0
1.1
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
0
18
0.00
0.40
0.0
1.1
—
1580.2
—
0
18
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
8
61
1.32
0.39
1.1
1.1
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
5
35
1.43
0.39
1.8
1.1
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
12
159
0.75
0.39
1.4
1.4
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
12
159
0.75
0.39
1.4
1.4
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
0
19
0.00
0.39
0.0
1.0
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
0
19
0.00
0.39
0.0
1.1
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
12
158
0.75
0.38
1.4
1.4
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
12
158
0.75
0.38
1.4
1.4
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
25
207
1.22
0.37
2.1
2.6
e9/l
4.6
4.0
0.58
20
175
(3035285) Chloride [Moles/volume] in Venous blood
5
37
1.36
0.37
6.0
2.9
mmol/l
105.2
105.6
—
5
37
(3041354) Potassium [Moles/volume] in Venous blood
5
37
1.36
0.37
6.0
2.9
mmol/l
4.0
4.0
—
5
37
(3033705) Calcium.ionized [Moles/volume] in Venous blood
5
37
1.36
0.37
6.0
2.9
—
—
—
0
0
(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood
5
37
1.36
0.37
1.0
1.2
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
10
72
1.40
0.37
1.2
1.6
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
31
263
1.19
0.37
3.5
1.9
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
31
263
1.19
0.37
3.1
1.9
—
—
—
0
0
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
9
70
1.29
0.37
1.3
1.1
—
8.4
—
0
8
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
133
1248
1.10
0.36
4.6
3.2
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
21
171
1.24
0.36
2.0
3.0
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
9
71
1.27
0.36
2.6
2.6
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
9
71
1.27
0.36
1.3
1.6
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
6
41
1.47
0.36
1.0
1.5
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
6
41
1.47
0.36
1.0
1.5
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
13
99
1.32
0.36
1.5
1.5
—
—
—
0
0
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
15
117
1.29
0.35
2.1
1.5
g/l
1.2
1.2
0.00
15
112
(3005988) Vibrio sp identified in Specimen by Organism specific culture
6
42
1.43
0.35
1.0
1.5
—
—
—
0
0
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
6
42
1.43
0.35
1.2
1.3
nmol/l
0.7
0.5
—
6
36
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
6
42
1.43
0.35
1.0
1.5
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
6
42
1.43
0.35
1.3
1.4
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
31
265
1.18
0.34
3.3
1.9
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
26
219
1.20
0.34
1.3
1.3
—
—
—
0
0
(3002256) Pathology report gross observation
43
379
1.15
0.34
1.3
1.2
—
—
—
0
0
(40768793) Breast Pathology biopsy report
10
74
1.36
0.32
1.3
1.2
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
17
207
0.81
0.31
1.8
1.4
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
12
93
1.30
0.30
1.6
1.1
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
28
241
1.17
0.30
3.3
2.0
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
51
562
0.89
0.28
1.7
1.4
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
8
63
1.28
0.28
1.1
1.2
—
—
—
0
0
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
8
63
1.28
0.28
1.4
1.2
—
1.0
—
0
6
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
9
120
0.74
0.27
1.3
1.5
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
30
262
1.16
0.27
3.4
1.6
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
12
150
0.79
0.27
1.7
1.6
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
163
1561
1.07
0.27
5.8
4.4
estimate
0.0
0.0
0.50
43
312
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
8
65
1.24
0.27
1.0
1.6
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
8
67
1.20
0.26
1.5
1.5
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
11
86
1.29
0.26
2.4
2.4
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
51
464
1.11
0.26
2.6
2.4
ug/g
125.0
109.8
0.14
36
368
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
5
74
0.67
0.26
1.0
1.3
—
—
—
0
0
(3000492) Spirometry study
30
340
0.87
0.26
1.4
1.3
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
14
114
1.24
0.25
1.6
1.7
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
9
74
1.22
0.25
4.3
4.1
—
—
—
0
0
(4010399)
23
198
1.17
0.25
1.4
1.4
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
13
105
1.25
0.25
3.6
3.7
g/l
3.3
0.3
—
7
53
(3007164) IgA [Mass/volume] in Serum or Plasma
73
783
0.92
0.25
1.6
1.4
g/l
2.2
2.3
0.32
49
496
(42529406) Shigella sp [Presence] in Stool by Culture
12
96
1.26
0.25
1.6
1.2
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
165
1586
1.07
0.24
4.5
3.2
estimate
0.0
0.0
0.00
39
296
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
80
748
1.09
0.24
3.9
3.9
%
21.0
21.7
0.11
28
320
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
9
77
1.17
0.24
1.0
1.1
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
28
247
1.14
0.23
5.0
4.5
ug/l
3.1
53.6
0.87
20
196
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
5
40
1.25
0.22
1.2
1.3
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
51
469
1.10
0.22
2.6
2.6
mmol/l
2.4
2.4
0.10
40
412
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
5
41
1.22
0.22
1.0
1.7
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
5
42
1.19
0.21
2.2
1.3
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
0
11
0.00
0.21
0.0
12.3
—
—
—
0
0
(3024263) Appearance of Synovial fluid
0
11
0.00
0.21
0.0
1.8
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
0
11
0.00
0.21
0.0
2.0
—
—
—
0
0
(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright
0
10
0.00
0.21
0.0
1.1
—
362.6
—
0
5
(3013727) Leukocytes other/100 leukocytes in Blood
0
10
0.00
0.21
0.0
4.3
—
47.9
—
0
10
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
0
10
0.00
0.21
0.0
1.2
—
8.3
—
0
10
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
0
12
0.00
0.21
0.0
1.5
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
5
43
1.16
0.21
1.0
1.0
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
0
13
0.00
0.21
0.0
1.4
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
6
49
1.23
0.20
2.7
2.7
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
47
508
0.92
0.19
1.3
1.5
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
11
90
1.23
0.19
1.5
1.2
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
61
571
1.08
0.19
1.7
1.7
—
—
—
0
0
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
7
58
1.21
0.18
3.6
2.6
u/ml
5.9
74.3
—
7
52
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
13
153
0.84
0.18
1.5
1.6
mg/l
4.2
2.8
—
6
111
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
89
847
1.07
0.18
1.5
1.3
u/ml
0.6
1.4
2.26
28
226
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
10
82
1.23
0.17
2.7
1.6
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
33
360
0.91
0.17
1.3
1.6
—
—
—
0
0
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
8
70
1.15
0.16
1.1
1.3
—
38.7
—
0
8
(3002523) Influenza virus A Ag [Presence] in Specimen
8
73
1.10
0.16
1.1
1.1
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
8
73
1.10
0.16
1.1
1.1
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
10
119
0.84
0.15
7.0
2.7
—
—
—
0
0
(3020961) Endomysium IgA Ab [Titer] in Serum
17
192
0.88
0.15
1.1
1.1
—
6.2
—
0
5
(40761535) Cells panel - Urine sediment
25
227
1.11
0.14
4.0
3.2
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
10
118
0.84
0.14
1.4
1.4
—
—
—
0
0
(3008898) HLA-B27 [Presence]
19
170
1.12
0.13
1.2
1.1
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
22
199
1.11
0.13
4.6
2.1
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
9
110
0.81
0.13
1.7
1.3
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
160
1562
1.04
0.12
4.4
3.2
estimate
0.0
0.0
0.00
43
308
(3019150) Specific gravity of Urine by Refractometry
74
712
1.05
0.11
4.5
3.3
kg/l
1.0
1.0
0.59
14
92
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
10
86
1.17
0.11
1.2
1.3
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
10
115
0.87
0.11
2.0
1.6
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
129
1260
1.04
0.10
3.0
2.5
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
5
46
1.09
0.09
1.0
1.1
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
5
48
1.04
0.09
1.0
1.1
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
97
944
1.04
0.09
4.2
2.8
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
6
54
1.11
0.09
1.2
1.1
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
12
107
1.13
0.08
1.5
1.6
iu/ml
0.0
0.0
—
5
25
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
57
549
1.04
0.08
2.8
2.8
ug/l
0.6
0.8
0.84
29
316
(4094501)
5
64
0.78
0.08
1.0
1.1
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
6
71
0.84
0.07
1.0
1.1
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
8
74
1.08
0.07
1.1
1.1
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
21
220
0.95
0.03
1.1
1.0
—
—
—
0
0
(4034850)
11
102
1.08
0.03
17.4
8.6
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
13
138
0.94
0.02
4.9
3.2
—
—
—
0
0
(3015736) pH of Urine
123
1238
0.99
0.01
3.8
3.0
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
11
109
1.01
0.00
1.3
1.1
—
—
—
0
0
(1002224) Polysomnography panel
17
167
1.02
0.00
1.1
1.1
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
69
686
1.01
0.00
4.2
3.1
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
30
304
0.99
0.00
1.4
1.2
—
—
—
0
0
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
13
134
0.97
0.00
2.6
1.7
nmol/l
41.0
38.6
0.13
13
129
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
0
7
0.00
0.00
0.0
1.3
—
2.1
—
0
7
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
0
9
0.00
0.00
0.0
1.6
—
—
—
0
0
(3038071) Oxygen [Partial pressure] in Mixed venous blood
0
7
0.00
0.00
0.0
8.9
—
—
—
0
0
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
0
6
0.00
0.00
0.0
10.0
—
—
—
0
0
(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.1
—
90.2
—
0
8
(3032352) Blasts [#/volume] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
6.6
—
—
—
0
0
(46235168) Fasting glucose [Moles/volume] in Blood
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
0
8
0.00
0.00
0.0
2.1
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3017115) Methotrexate [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
21.8
—
0.4
—
0
6
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3011544) Albumin [Mass/volume] in Pleural fluid
0
5
0.00
0.00
0.0
1.0
—
19.6
—
0
5
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3022229) Phosphate [Moles/volume] in Urine
0
5
0.00
0.00
0.0
3.4
—
11.6
—
0
5
(3021162) Amylase [Enzymatic activity/volume] in Specimen
0
5
0.00
0.00
0.0
3.0
—
3699.8
—
0
5
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.4
—
12.4
—
0
7
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
16
160
1.00
0.00
1.4
1.3
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
3.0
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: ST19_CONTU_TOES_W_DAMAGE_NAIL – Contusion of toe(s) with damage to nail
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).